GGrantIndex
Sort

23,748 grants matching melanoma

Gene therapy of cancer

$2,518,659
Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

AMERICAN COLLEGE OF SURGEONS ONCOLOGY GROUP

$2,517,101
Duke University · U10 · FY2000 · CA

Consolidated Basic Cancer Research Program

$2,516,380
Dario C. Altieri · Wistar Institute · P30 · FY2014 · CA

Nano Approaches to Modulate Host Cell Response for Cancer Therapy

$2,512,234
Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2016 · CA

Cancer Center Support Grant

$2,512,026
William L. Carroll · New York University School Of Medicine · P30 · FY2012 · CA

Cancer Center Support Grant

$2,512,026
William L. Carroll · New York University School Of Medicine · P30 · FY2011 · CA

An integrated translational approach to overcome drug resistance

$2,500,407
Ryan Bruce Corcoran · Massachusetts General Hospital · U54 · FY2017 · CA

Yale SPORE in Skin Cancer

$2,500,000
Marcus W Bosenberg · Yale University · P50 · FY2018 · CA

Targeted Therapies in Melanoma

$2,498,687
Meenhard Herlyn · Wistar Institute · P01 · FY2020 · CA

Targeted Therapies in Melanoma

$2,498,463
Meenhard Herlyn · Wistar Institute · P01 · FY2017 · CA

Role of microbiome in cancer and inflammation

$2,496,470
Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Targeted Therapies in Melanoma

$2,496,009
Meenhard Herlyn · Wistar Institute · P01 · FY2016 · CA

Experimental Therapy for Brain Tumors

$2,494,255
David M. Ashley · Duke University · P01 · FY2022 · CA

Targeted Therapies in Melanoma

$2,487,446
Meenhard Herlyn · Wistar Institute · P01 · FY2021 · CA

Targeted Therapies in Melanoma

$2,485,489
Meenhard Herlyn · Wistar Institute · P01 · FY2015 · CA

CALIFORNIA TEACHERS STUDY

$2,482,687
Leslie Bernstein · Beckman Research Institute/City Of Hope · R01 · FY2008 · CA

(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank

$2,481,702
Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2022 · CA

Targeted Therapies in Melanoma

$2,478,587
Meenhard Herlyn · Wistar Institute · P01 · FY2023 · CA

Combination Therapies to Defeat Melanoma Resistance

$2,478,520
Antoni Ribas · University Of California Los Angeles · P01 · FY2024 · CA

Studies of Populations Exposed to Occupational Sources of Radiation

$2,475,812
Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA

The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis

$2,474,858
William G Stetler-Stevenson · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

Molecular Diagnostics Core Laboratory

$2,468,096
Liqiang Xi · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank

$2,467,614
Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2023 · CA

Experimental Therapy for Brain Tumors

$2,461,078
John H Sampson · Duke University · P01 · FY2019 · CA

NKG7-ARMED TUMOR-INFILTRATING LYMPHOCYTE THERAPY FOR METASTATIC UVEAL MELANOMA

$2,455,718
Mayo Clinic · · FY2025 · Defense Health Agency